SYMETIS
Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurateâ„¢Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.
SYMETIS
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Ecublens, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.bostonscientific.com
Total Employee:
51+
Status:
Active
Contact:
+41216510160
Email Addresses:
[email protected]
Total Funding:
56.7 M USD
Technology used in webpage:
Sectigo SSL Sectigo Domain SSL CSC Global DNS Online.net MailCleaner
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
VectivBio
VectivBio is a biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-02-15 | Middle Peak Medical | Middle Peak Medical acquired by Symetis | N/A |
Investors List
Endeavour Vision
Endeavour Vision investment in Series D - Symetis
Swisscom Ventures
Swisscom Ventures investment in Venture Round - Symetis
Endeavour Vision
Endeavour Vision investment in Series C - Symetis
NBGI Ventures
NBGI Ventures investment in Series C - Symetis
Banexi Ventures
Banexi Ventures investment in Series B - Symetis
Aravis Ventures
Aravis Ventures investment in Series B - Symetis
VINCI CAPITAL
VINCI CAPITAL investment in Series B - Symetis
Truffle Capital
Truffle Capital investment in Series B - Symetis
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Symetis
Wellington Partners
Wellington Partners investment in Series B - Symetis
Official Site Inspections
http://www.bostonscientific.com
- Host name: aa089eb6179d1ae2b.awsglobalaccelerator.com
- IP address: 13.248.160.137
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
